Community Pharmacy England (CPE) - News updates
Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension MSN/2026/016 Tier 2 – medium impact Date of issue: 25 February 2026 Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free will be out of stock from mid-March until June 2026. Co-trimoxazole 80mg/400mg/5ml [...] The post Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension appeared first on Community Pharmacy England.
Seasonal vaccination provider guide published
NHS England have published a guide to support vaccinations sites who intend to participate in the seasonal spring 2026 programme for COVID-19 vaccination. The guide outlines how providers should deliver the Spring 2026 COVID‑19 vaccination programme, including operational processes, eligible groups, system usage, supply arrangements, and payment mechanisms. The guide is available via the NHS [...] The post Seasonal vaccination provider guide published appeared first on Community Pharmacy England.
Prices for first 11 Category H products published in the March 2026 Drug Tariff
The reimbursement prices for the first 11 multi-source products moving from Category C to the new Category H have been published in the March 2026 Drug Tariff. Prices for 6 products have increased whereas 5 products have seen a decrease compared to their previous Category C prices. Ursodeoxycholic acid 500mg tablets (100) has the largest [...] The post Prices for first 11 Category H products published in the March 2026 Drug Tariff appeared first on Community Pharmacy England.
Drug Tariff Watch – March 2026
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2026. Part VIIIA – Basic prices of drugs Contractors should note changes made to the notes to Part VIIIA regarding Categories A, C, H and M. [...] The post Drug Tariff Watch – March 2026 appeared first on Community Pharmacy England.
PQS reminder: Declaration closes this Friday
Pharmacy owners have until 11.59pm on Friday (27th February 2026) to make their Pharmacy Quality Scheme (PQS) 2025/26 declaration through the MYS portal, as the window for claiming this payment will then close. Pharmacy owners must have evidence to demonstrate meeting the gateway criterion and the domains that they have claimed for by the end of 31st [...] The post PQS reminder: Declaration closes this Friday appeared first on Community Pharmacy England.
MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens
A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro KwikPen 15mg solution for injection in pre-filled pen only. The issue was identified due to faults with the pens, where in [...] The post MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited)
MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) Drug alert number: EL(26)A/10 Date issued: 24 February 2026 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. DMRC reference number: DMRC-38371734 Marketing Authorisation Holder: Rayner [...] The post MHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) appeared first on Community Pharmacy England.
MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd)
MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) Drug alert number: EL(26)A/09 Date issued: 23 February 2026 Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results. DMRC reference number: DMRC-38487919 Company name: Sterling [...] The post MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) appeared first on Community Pharmacy England.
Data Security and Protection Toolkit 2026 workshop now on-demand
Pharmacy owners can now watch a recording of Community Pharmacy England’s recent online workshop to help with the completion of the Data Security and Protection Toolkit for 2026. Around 270 people registered for last week’s webinar, which aimed to support community pharmacy owners with making their toolkit submission. Feedback from the webinar indicates that over 80% [...] The post Data Security and Protection Toolkit 2026 workshop now on-demand appeared first on Community Pharmacy England.
Refining negotiating asks and preparing for the year ahead at February meeting
Community Pharmacy England met in London for a full Committee meeting on 4th and 5th February. Committee Members examined economic and other analysis to confirm key negotiating positions for the imminent 2026/27 contractual negotiations, looking at a wide range of topics including funding needs, services, infrastructure investment, and regulatory reform. The Department of Health and Social Care and [...] The post Refining negotiating asks and preparing for the year ahead at February meeting appeared first on Community Pharmacy England.